Patent ID: 9133261
Filing Date: 2015-09-15
Classification: A61K,A61P,C07K

Abstract:
1. A compound selected from the group consisting of: (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib (Aib or a pharmaceutically acceptable salt thereof, wherein: Abu is α-aminobutyric acid, A5c is 1-amino-1-cyclopentanecarboxylic acid, A6c is 1-amino-1-cyclohexanecarboxylic acid, Act is Aib is α-aminoisobutyric acid, Apc is Cha is β-cyclohexylalanine, Dhp is 3,4-dehydroproline, Dmt is 5,5-dimethylthiazolidine-4-carboxylic acid, 2Fua is β-(2-furyl)-alanine, Ktp is 4-ketoproline, Orn is ornithine, 2Pal is β-(2-pyridinyl)alanine, 3Pal is β-(3-pyridinyl)alanine, Pip is pipecolic acid, Taz is 2Thi is β-(2-thienyl)alanine, Thz is thiazolidine-4-carboxylic acid, and Glu(NH-Hexyl) is